
PROTAC BRD4 ligand-1
CAS No. 2313230-51-0
PROTAC BRD4 ligand-1( —— )
Catalog No. M33078 CAS No. 2313230-51-0
PROTAC BRD4 ligand-1, a component of Protac GNE-987, is a ligand for BRD4 and acts as an inhibitor of BET.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 190 | Get Quote |
![]() ![]() |
5MG | 297 | Get Quote |
![]() ![]() |
10MG | 496 | Get Quote |
![]() ![]() |
25MG | 908 | Get Quote |
![]() ![]() |
50MG | 1527 | Get Quote |
![]() ![]() |
100MG | 2151 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePROTAC BRD4 ligand-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPROTAC BRD4 ligand-1, a component of Protac GNE-987, is a ligand for BRD4 and acts as an inhibitor of BET.
-
DescriptionPROTAC BRD4 ligand-1 is a potent BET inhibitor and a ligand for target BRD4 protein for PROTACT GNE-987 (HY-129937A).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorEpigenetic Reader Domain | Ligands for Target Protein for PROTAC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2313230-51-0
-
Formula Weight500.47
-
Molecular FormulaC23H18F2N4O5S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 5 mg/mL (9.99 mM; Ultrasonic )
-
SMILESCn1cc2-c3cc(CS(C)(=O)=O)c(cc3N(Cc3c[nH]c(c23)c1=O)c1ncc(F)cc1F)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pillow TH, et al. Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity. ChemMedChem. 2019 Oct 31.?
molnova catalog



related products
-
ZEN-3694
ZEN-3694 (ZEN 3694) is a bromo-structural domain extra-terminal inhibitor (BETi) with activity in androgen signaling inhibitor (ASI) resistance models and can be used in combination with enzalutamide to study metastatic desmoplasia-resistant prostate cancer.
-
Y06036
Y06036 a potent and selective BET inhibitor can bind to the BRD4(1) bromodomain (Kd: 82 nM).
-
ZL0580
ZL0580 induces HIV suppression by inhibiting Tat transactivation and transcription elongation as well as by inducing repressive chromatin structure at the HIV promoter.